|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
BayBio’s Annual Conference, Tweet by Tweet
|
Luke Timmerman |
04/22/11 |
San Francisco
|
|
Zacharon Aligns with Pfizer, Conatus Raises Big Bucks, Software Veteran Wins Wireless Institute Challenge, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
04/14/11 |
San Diego
|
|
The New Tech Bubble, Biotech Vs. Big Pharma, and More Thoughts from Boston BD Conference
|
Gregory T. Huang |
04/14/11 |
Boston
|
|
Conatus Adds $7.5M, Closes Series B Round
|
Bruce V. Bigelow |
04/13/11 |
San Diego
|
|
Conatus Pharmaceuticals Secures $7,500,000 Series B Financing
|
VentureDeal |
04/13/11 |
San Diego
|
|
Genzyme-Spinout Peptimmune Files for Chapter 7 Liquidation
|
Ryan McBride |
03/23/11 |
Boston
|
|
Patients’ Parents Upset By FDA Panel’s Rejection of Lilly/Alnara’s Cystic Fibrosis Drug
|
Ryan McBride |
01/19/11 |
Boston
|
|
Theraclone Strikes $632M Deal With Pfizer to Discover Antibodies for Cancer, Infections
|
Luke Timmerman |
01/18/11 |
Seattle
|
|
Allozyne Passes First Clinical Trial, Dreams Big About a Once-Monthly Multiple Sclerosis Drug
|
Luke Timmerman |
01/10/11 |
Seattle
|
|
23andMe Adds $9M to VC Round
|
Luke Timmerman |
01/07/11 |
San Francisco
|
|
23andMe Secures $9,000,000 Series C Financing Round
|
VentureDeal |
01/07/11 |
San Francisco
|
|
Syndax Pharma Study Offers Clues that Lung Cancer Treatment Could Benefit Subset of Patients
|
Ryan McBride |
12/10/10 |
Boston
|
|
Lilly Funds Cerulean, Genzyme Sells Diagnostics Unit, Roche Ends RNAi Program, & More Boston-Area Life Sciences News
|
Erin Kutz |
11/19/10 |
Boston
|
|
Verastem, Founded by MIT Big Names, Raises $16M to Fight Cancer Stem Cells
|
Luke Timmerman |
11/16/10 |
Boston
|
|
Verastem Secures $16,000,000 Series A Round
|
VentureDeal |
11/16/10 |
Boston
|
|
Aires Pharmaceuticals Secures $20,000,000 Series B Round
|
VentureDeal |
11/12/10 |
San Diego
|
|
Ceregene Adds $11.5M
|
Luke Timmerman |
11/11/10 |
San Diego
|
|
Ceregene Lands $11,500,000 Series D Round
|
VentureDeal |
11/11/10 |
San Diego
|
|
Acceleron Pharma Cuts 40 Percent of Workforce
|
Luke Timmerman |
11/03/10 |
Boston
|
|
Genzyme Sheds Testing Unit, Red Bend Acquires VirtualLogix, Acceleron Forges Alliance with Shire, & More Boston-Area Deals News
|
Rebecca Zacks |
09/15/10 |
Boston
|
|
Pfizer Axes Celldex Agreement, Vertex’s Telaprevir Performs in Clinical Trial, Anchor Therapeutics Inks Potential $480M Deal With J&J, & More Boston-Area Life Sciences News
|
Rebecca Zacks |
09/10/10 |
Boston
|
|
Rhythm Boosts Series A Round to $40M, Adds Third Rock Ventures to List of Backers
|
Ryan McBride |
09/08/10 |
Boston
|
|
Rhythm Pharmaceuticals Garners $19,000,000 Series A Financing
|
VentureDeal |
09/08/10 |
Boston
|
|
$30M Series F for EndoGastric
|
Wade Roush |
08/30/10 |
San Francisco
|
|
EndoGastric Solutions Secures $30,000,000 Series F Round
|
VentureDeal |
08/30/10 |
Seattle
|
|
Blue Cod and Viridity Bag $8M Apiece, Aprendica and Arbor Networks Acquired, & More Boston-Area Deals News
|
Rebecca Zacks |
08/11/10 |
Boston
|
|
Syndax Pharma Snags $6M Debt Deal
|
Ryan McBride |
08/09/10 |
Boston
|
|
Eli Lilly Pays up to $380M for Alnara Pharma
|
Ryan McBride |
07/20/10 |
Boston
|
|
Allozyne, After a Stealthy Year on a Slim Budget, Re-Emerges with MS Drug and Fat Pipeline
|
Luke Timmerman |
07/14/10 |
Seattle
|
|
Trivascular Secures $60,000,000 Series C Financing
|
VentureDeal |
07/13/10 |
San Francisco
|
|
Page 2 of
6 |
« previous page · next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.